Newborn screening in Turkey
INFAI and Bruker BioSpin are currently conducting a pilot study to establish NMR spectroscopy in the screening of newborn babies for inborn errors of metabolism.Inborn errors of metabolism affect 1 in 1000 newborns in Central Europe, and an even higher number, 1 in 500, in Turkey.Urine samples of 1500 healthy newborns will be collected on their third day of life in 15 study centers in 8 cities all over Turkey (see map below).The data from healthy newborn babies will be essential as a statistical basis to detect babies suffering from IEM as outliers from the statistical model of "normality".
More details can be found in a poster that was presented at the 2011 SSIEM, or in a short brochure.
|